Home > News > Health > Renown earns third national cancer accreditation

Renown earns third national cancer accreditation

By ThisIsReno

SUBMITTED NEWS RELEASE

Renown Institute for Cancer has earned a three-year accreditation with the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons.

The new breast cancer accreditation makes it the only healthcare network in the region to retain all three cancer accreditations including the region’s first and only Radiation Oncology Accreditation (ACR-RO), earned earlier this year in January, and the region’s first Comprehensive Cancer Program Accreditation (ACoS CoC), which the institute has held for more than 23 years.

These three accreditations are the most any cancer program of this size can attain in the region.

Accreditation by the NAPBC is only given to those centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance.

During the survey process, the center must demonstrate compliance with standards established by the NAPBC for treating women who are diagnosed with the full spectrum of breast disease. The standards include proficiency in the areas of center leadership, clinical management, research, community outreach, professional education and quality improvement.

A breast center that achieves NAPBC accreditation has demonstrated a firm commitment to offer its patients every significant advantage in their journey with breast disease.

“Renown Institute for Cancer’s breast accreditation highlights our commitment to our patients,” said Bobbi Gillis, RN, CBCB, BSN, Breast Health Nurse Navigator and Breast Program Coordinatorat Renown Institute for Cancer. “Given our continuous efforts to reach new levels of excellence and care for cancer patients, this latest development underscores our commitment to continuous improvement and the teamwork and collaboration required to exceed national standards.”

Earned in January 2011, the ACR-RO is the only one in northern Nevada and northern California. Only 222 facilities in the United States have received ACR-RO Accreditation for Radiation Oncology.

In addition to being the region’s only nationally accredited cancer center in three disciplines, Renown also offers the region’s only TomoTherapy program, which applies therapeutic radiation to treat tumors with 3-D imaging daily and improved precision. When TomoTherapy was installed in November of 2008, only two percent of hospitals nation-wide had the technology.

Other types of treatment include 3-D conformal; Image Guided Radiation Therapy; Intensity Modulated Radiation Therapy; Stereotactic Radiosurgery; Stereotactic Body Radiation Therapy; High Dose Rate Brachytherapy for breast, GYN and Prostate and Low Dose Rate Brachytherapy, commonly performed for prostate cancer.

About Renown Institute for Cancer

Renown Institute for Cancer has been the region’s first hospital recognized by the American College of Surgeons Commission on Cancer for comprehensive cancer care for more than 22 years. Only 25 percent of hospitals nationwide meet the Commission’s rigorous standards.

Renown Institute for Cancer is the largest healthcare provider in the area conducting clinical trials with the National Cancer Institute. Clinical trials allow patients to be on leading trends in medicine and often times they become involved in that “next big discovery” for cancer treatments. Leading northern Nevada in cancer research, Renown Institute for Cancer has administered more than 135 trials to 870 participants.

Whether individuals have been referred, are currently receiving treatment or are seeking a second opinion, they can make an appointment at Renown Institute for Cancer anytime. The team of skilled professionals brings expertise and comprehensive resources to patient care. For general inquiries, contact 775-982-6830 or visit www.renown.org/cancer.

Never miss a story

Get independent Reno news headlines in your inbox five days a week.

Email field is required to subscribe.